<--- Back to Details
First PageDocument Content
Dosage forms / Pharmaceutical industry / Pharmacokinetics / Clinical research / Bioequivalence / Pharmaceutical formulation / Nasal spray / Dry powder inhaler / Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Medicine
Date: 2006-03-22 14:44:50
Dosage forms
Pharmaceutical industry
Pharmacokinetics
Clinical research
Bioequivalence
Pharmaceutical formulation
Nasal spray
Dry powder inhaler
Food and Drug Administration
Pharmaceutical sciences
Pharmacology
Medicine

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 3,35 MB

Share Document on Facebook

Similar Documents

NEWS RELEASE Copley Scientific previews 3rd generation TPK Critical Flow Controller at upcoming RDD Europe 2017 New TPK™ 2100 Critical Flow Controller offers faster, more accurate dry powder inhaler testing March 28th

DocID: 1uSld - View Document

NEWS RELEASE Copley Scientific to showcase new TPK™ 2100 Critical Flow Controller for dry powder inhaler testing at DDL2017 A highly automated system to speed up testing, improve reproducibility, and enhance data outpu

DocID: 1u3wN - View Document

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION ASMANEX® Twisthaler® Mometasone Furoate Dry Powder Inhaler

DocID: 1tYoJ - View Document

Health / Asthma / Respiratory therapy / Smoking / Inhaler / Chronic obstructive pulmonary disease / Metered-dose inhaler / Dry powder inhaler / Medicine / Dosage forms / Pharmacology

Combivent Metered Aerosol CMI

DocID: 1fCg1 - View Document

Asthma / Respiratory therapy / GlaxoSmithKline / Dosage forms / Fluticasone/salmeterol / Salmeterol / Inhaler / Dry powder inhaler / Medicine / Pulmonology / Pharmacology

Novel  Dual-­Chamber  Dry  Powder  Inhaler  for  Combination  Therapy     Martin  J.  Donovan1,  Aileen  Gibbons2,  Hugh  D.C.  Smyth2  and  Jacques  Pappo1      1  Respira  Therapeutics  Inc

DocID: 1ar2O - View Document